Here is the PROTOCOL explained much better than I can:::::::::::
>>>>>>>>>>>>>
AAFP Vaccination Recommendations
The American Association of Feline Practitioners and the Academy of Feline Medicine have actively participated in efforts to investigate the causal link of vaccinations to the development of tumors and have established two general guidelines for vaccine administration.
Veterinarians should standardize vaccination protocols within their practice and document the location of the vaccination, the type of vaccine administered, and the manufacturer of the vaccine in the patient's permanent record.
The following vaccine sites are recommended:
Vaccines containing antigens panleukopenia, feline herpesvirus I, feline calicivirus (+/-Chlamydia) should be administered in the right fore region (RF) or be given intranasally. (IN).
Vaccines containing leukemia virus antigen (+/- other antigens) should be administered in the left rear region (LR) according to manufacturer's recommendations. Leukemia=Left.
Vaccines containing rabies antigen (+/- other antigens) should be administered in the right rear region (RR) according to the manufacturer's recommendations. Rabies=Right.
Feline Vaccine Protocol
Vaccine Antigen Age at Initial Vaccination Booster Interval Panel Comments
Under 12 weeks Over 12 weeks
Panleukopenia
parenteral MLV
intranasal MLV vaccinate at inital visit and then every 3-4 wks until >12 weeks 1 1 dose 1 year later, then every 3 years Highly recommended. Not for use in pregnant queens or kittens <4 wks or immune compromised
Panleukopenia
killed vaccinate at inital visit and then every 3-4 wks until >12 weeks 2 doses
3-4 wks apart 1 year later, then every 3 years Highly recommended
FHV-1/FCV * 2
parenteral MLV
intranasal MLV vaccinate at inital visit and then every 3-4 wks until >12 weeks 1 dose 1 year later, then every 3 years 3 Highly recommended
FHV-1/FCV *
killed vaccinate at inital visit and then every 3-4 wks until >12 weeks 2 doses
3-4 wks apart 1 year later, then every 3 years 3 Highly recommended
Rabies
killed 1 dose 1 year later, then every 3 years 5 Highly recommended for all cats
Chlamydia
avirulent live 1 dose 1 dose 1 year later, then annually Recommended for use in cats at high risk of exposure
Chlamydia
killed 2 doses
3-4 wks apart 2 doses
3-4 wks apart 1 year later, then annually Recommended for use in cats at high risk of exposure
FIP
intranasal MLV 2 doses
3-4 wks apart not earlier than 16 wks 1 year later, then annually It is reasonable to vaccinate cats at risk of exposure to other cats with known or clinically suspected exposure to feline corona virus
FeLV
killed 2 doses
3-4 wks apart;
1st dose > 8 wks;
2nd dose >12 wks 2 doses
3-4 wks apart 1 year later, then annually Follow testing recommendatons as published in the AAFP/AFM Recommendation for Feline Retrovirus Testing. Recommended for use in cats with high risk 4 of exposure.
M. Canis
killed Prevention:
3 doses; 2 wks between 1st and 2nd, then 3rd dose 3 wks after 2nd dose.
Treatment:
3 doses; 2 wks between 1st and 2nd, then 3rd dose 3 wks after 2nd dose. 3rd dose is at DVM discretion. Guidelines for long term use or booster intervals not available Not recommended for routine use. Insufficient data to evaluate use in prevention or elimination of M. Canis infection.
Notes:
Parenteral or intranasal vaccination of kittens between 4-6 weeks of age in high risk environments (catteries, shelters) and orphaned kittens may be indicated.
In environments with enzootic viral respiratory infection vaccination of kittens >2 weeks of age may be indicated using intranasal FHV-1/FCV or > 4 weeks of age with parenteral FHV-1/FCV.
Interval of booster vaccination based on risk of exposure. Cats at high risk, such as those entering boarding facilities or shown frequently at cat shows, may benefit from more frequent revaccination. Duration of immunity beyond one year is based on antibody titers and not challenge.
High risk of exposure to FeLV: includes outdoor cats, indoor/outdoor cats, stray/feral cats, open multi-cat households, FeLV positive households, and households with unknown FeLV status. Low risk of exposure to FeLV would include indoor cats and closed multi-cat households that are tested negative.
While the panel recommended boosters at three year intervals, actual protocols must comply with all local statutes.
*FHV-1/FCV = feline herpes virus 1 and calici virus
For Further Information:
1998 Report of the American Association of Feline Practitioners and Academy of Feline Medicine Advisory Panel on Feline Vaccines. J AM Vet Med Assoc 1998; 212:227-241. Related Link:
Establishing Vaccination Protocols for Catteries
http://www.winnfelinehealth.org/heal...catteries.html
>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>
>>>>>>>>>>>>>
AAFP Vaccination Recommendations
The American Association of Feline Practitioners and the Academy of Feline Medicine have actively participated in efforts to investigate the causal link of vaccinations to the development of tumors and have established two general guidelines for vaccine administration.
Veterinarians should standardize vaccination protocols within their practice and document the location of the vaccination, the type of vaccine administered, and the manufacturer of the vaccine in the patient's permanent record.
The following vaccine sites are recommended:
Vaccines containing antigens panleukopenia, feline herpesvirus I, feline calicivirus (+/-Chlamydia) should be administered in the right fore region (RF) or be given intranasally. (IN).
Vaccines containing leukemia virus antigen (+/- other antigens) should be administered in the left rear region (LR) according to manufacturer's recommendations. Leukemia=Left.
Vaccines containing rabies antigen (+/- other antigens) should be administered in the right rear region (RR) according to the manufacturer's recommendations. Rabies=Right.
Feline Vaccine Protocol
Vaccine Antigen Age at Initial Vaccination Booster Interval Panel Comments
Under 12 weeks Over 12 weeks
Panleukopenia
parenteral MLV
intranasal MLV vaccinate at inital visit and then every 3-4 wks until >12 weeks 1 1 dose 1 year later, then every 3 years Highly recommended. Not for use in pregnant queens or kittens <4 wks or immune compromised
Panleukopenia
killed vaccinate at inital visit and then every 3-4 wks until >12 weeks 2 doses
3-4 wks apart 1 year later, then every 3 years Highly recommended
FHV-1/FCV * 2
parenteral MLV
intranasal MLV vaccinate at inital visit and then every 3-4 wks until >12 weeks 1 dose 1 year later, then every 3 years 3 Highly recommended
FHV-1/FCV *
killed vaccinate at inital visit and then every 3-4 wks until >12 weeks 2 doses
3-4 wks apart 1 year later, then every 3 years 3 Highly recommended
Rabies
killed 1 dose 1 year later, then every 3 years 5 Highly recommended for all cats
Chlamydia
avirulent live 1 dose 1 dose 1 year later, then annually Recommended for use in cats at high risk of exposure
Chlamydia
killed 2 doses
3-4 wks apart 2 doses
3-4 wks apart 1 year later, then annually Recommended for use in cats at high risk of exposure
FIP
intranasal MLV 2 doses
3-4 wks apart not earlier than 16 wks 1 year later, then annually It is reasonable to vaccinate cats at risk of exposure to other cats with known or clinically suspected exposure to feline corona virus
FeLV
killed 2 doses
3-4 wks apart;
1st dose > 8 wks;
2nd dose >12 wks 2 doses
3-4 wks apart 1 year later, then annually Follow testing recommendatons as published in the AAFP/AFM Recommendation for Feline Retrovirus Testing. Recommended for use in cats with high risk 4 of exposure.
M. Canis
killed Prevention:
3 doses; 2 wks between 1st and 2nd, then 3rd dose 3 wks after 2nd dose.
Treatment:
3 doses; 2 wks between 1st and 2nd, then 3rd dose 3 wks after 2nd dose. 3rd dose is at DVM discretion. Guidelines for long term use or booster intervals not available Not recommended for routine use. Insufficient data to evaluate use in prevention or elimination of M. Canis infection.
Notes:
Parenteral or intranasal vaccination of kittens between 4-6 weeks of age in high risk environments (catteries, shelters) and orphaned kittens may be indicated.
In environments with enzootic viral respiratory infection vaccination of kittens >2 weeks of age may be indicated using intranasal FHV-1/FCV or > 4 weeks of age with parenteral FHV-1/FCV.
Interval of booster vaccination based on risk of exposure. Cats at high risk, such as those entering boarding facilities or shown frequently at cat shows, may benefit from more frequent revaccination. Duration of immunity beyond one year is based on antibody titers and not challenge.
High risk of exposure to FeLV: includes outdoor cats, indoor/outdoor cats, stray/feral cats, open multi-cat households, FeLV positive households, and households with unknown FeLV status. Low risk of exposure to FeLV would include indoor cats and closed multi-cat households that are tested negative.
While the panel recommended boosters at three year intervals, actual protocols must comply with all local statutes.
*FHV-1/FCV = feline herpes virus 1 and calici virus
For Further Information:
1998 Report of the American Association of Feline Practitioners and Academy of Feline Medicine Advisory Panel on Feline Vaccines. J AM Vet Med Assoc 1998; 212:227-241. Related Link:
Establishing Vaccination Protocols for Catteries
http://www.winnfelinehealth.org/heal...catteries.html
>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>
